Brief: IntelGenx Receives USPTO Allowance Notice For Loxapine Orange Book Eligible Patent
21/02/2023 13:16
Feb 21 (Reuters) - Intelgenx Technologies Corp IGX.TO :
* INTELGENX RECEIVES USPTO NOTICE OF ALLOWANCE FOR LOXAPINE
ORANGE
BOOK ELIGIBLE PATENT
Source text for Eikon: ID:nGNX5FdTv0
Further company coverage: IGX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA